tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market
KZR
Kezar Life Sciences
RESEARCH TOOLSreports

Kezar Life Sciences (KZR) Financial Statements

473 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently $54.40M. The company's EPS TTM is $-1.99; its P/E ratio is -0.82; Kezar Life Sciences is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 7.00M$ 0.00$ 0.00
Gross Profit$ -897.00K$ -1.04M$ 7.00M$ 0.00$ -1.51M
Operating Income$ -52.27M$ -90.61M$ -111.42M$ -71.16M$ -54.66M
EBITDA$ -51.37M$ -81.10M$ -99.25M$ -66.03M$ -52.96M
Net Income$ -56.03M$ -83.74M$ -101.87M$ -68.24M$ -54.63M
Balance Sheet
Cash & Short-Term Investments$ 71.88M$ 132.25M$ 201.37M$ 276.56M$ 208.35M
Total Assets$ 76.65M$ 144.68M$ 221.24M$ 299.57M$ 217.93M
Total Debt$ 2.33M$ 16.18M$ 18.93M$ 21.26M$ 14.04M
Net Debt$ -69.55M$ -25.57M$ -16.56M$ -19.19M$ -48.84M
Total Liabilities$ 6.57M$ 27.77M$ 33.66M$ 29.70M$ 21.06M
Stockholders' Equity$ 70.07M$ 116.92M$ 187.57M$ 269.87M$ 196.88M
Cash Flow
Free Cash Flow$ -51.78M$ -74.24M$ -83.45M$ -60.42M$ -42.75M
Operating Cash Flow$ -51.78M$ -74.21M$ -81.64M$ -58.85M$ -42.44M
Investing Cash Flow$ 92.46M$ 80.43M$ 76.05M$ -91.39M$ -28.44M
Financing Cash Flow$ -10.59M$ 103.00K$ 638.00K$ 127.86M$ 112.58M
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Income Statement >

Kezar Life Sciences Debt to Assets

Balance Sheet >

Kezar Life Sciences Cash Flow

Cash Flow >

Kezar Life Sciences Forecast EPS vs Actual EPS

Earnings >